整形外科軟部組織修復市場レポート：手技別、損傷部位別、エンドユーザー別、地域別、2025～2033年

世界の整形外科軟部組織修復市場規模は2024年に38億米ドルに達しました。今後、IMARC Groupは、2033年には54億米ドルに達し、2025～2033年にかけて3.94%の成長率（CAGR）を示すと予測しています。高齢者の増加、医療セグメントにおける継続的な技術進歩、スポーツ活動への参加者の増加などが、市場成長を後押しする主要因となっています。

整形外科軟部組織修復市場分析

• 主要市場促進要因：プロスポーツへの市場参入企業の増加により、スポーツ関連傷害のリスクが大幅に増加しており、これが整形外科軟部組織修復市場の需要を促進しています。さらに、整形外科の靭帯断裂による複雑な神経筋痛の管理に有効な多血小板血漿などの新しい治療法の導入が、産業の成長を促進しています。
• 主要市場動向：バイオプリンティング、生物学的メッシュ、バイオファブリケーションなどの先端技術の浸透が進み、整形外科軟部組織修復市場の需要が拡大すると予想されます。また、広範な研究開発（R&D）活動、新しいデバイスや治療法の革新、1人当たりヘルスケア支出の増加も市場成長に寄与しています。
• 競合情勢：整形外科軟部組織修復市場の主要企業としては、Arthrex Inc.、Becton Dickinson and Company、Boston Scientific Corporation、CONMED Corporation、Integra LifeSciences、Johnson & Johnson、LifeNet Health、MTF Biologics、Smith & Nephew plc、Stryker Corporation、Tissue Regenix Group plc、Zimmer Biometなどが挙げられます。
• 地理的動向：北米と欧州が整形外科軟部組織修復市場で大きなシェアを占めています。高齢化人口の多さ、スポーツ関連傷害の有病率の高さ、先進的ヘルスケアインフラ、充実した償還制度など、数多くの要因がこれらの地域の市場成長に寄与しています。さらに、アジア太平洋では、ヘルスケアインフラの改善、可処分所得の増加、先進的治療オプションに対する意識の高まりが市場拡大の原動力となっています。
• 課題と機会：軟部組織処置のコスト抑制、規制上のハードル、技術の複雑さ、主要企業間の競争の激化などが、市場が直面している主要課題です。しかし、継続的な研究開発努力により、軟部組織修復のための革新的な技術や生体材料が開発され、手技の結果や患者の回復時間が改善され、産業の需要が高まっています。

整形外科軟部組織修復市場動向

整形外科的損傷の増加

整形外科的損傷の増加が整形外科軟部組織修復市場を大きく前進させています。運動やスポーツへの参加者の増加が整形外科的損傷の発生率の上昇につながっています。National Athletic Trainers'Associationによると、米国では2022年に約3,000万人の幼児が組織型スポーツに参加しています。この数字は、青少年スポーツリーグの人気が高まるにつれ、時間の経過とともに上昇しています。このことがスポーツ傷害の数をさらにエスカレートさせています。例えば、米国疾病予防管理センター（CDC）が発表した紙製によると、米国では毎年350万人以上のスポーツ関連傷害が発生しています。これに加えて、2022年にカナダで実施された調査では、カナダの高校でコンタクトスポーツの参加者にかなりの割合で負傷者がいることが明らかになりました。この調査では、負傷率はラグビーでは年間参加者100人当たり12.7人から、ICEでは年間参加者100人当たり33.1人とばらつきがあることもわかりました。頭部外傷の有病率は33.3％、手首または手の負傷は16.0％、肩の負傷は12.8％、膝の負傷は12.0％でした。これは軽傷と大怪我の両方をカバーしています。身体活動やスポーツをする機会が増えるにつれ、軟部組織の損傷を負う可能性は高くなります。これらの損傷は、靭帯断裂から腱断裂まで多岐にわたり、修復のために外科的介入を必要とします。これとは別に、人口の高齢化と変形性関節症などの慢性疾患の有病率の上昇も、軟部組織修復を含む整形外科的介入に対する需要を押し上げています。例えば、Cleveland Clinicが発表した紙製によると、55歳以上の成人の80％以上が変形性関節症を患っています。さらに、整形外科的健康の重要性に対する意識の高まりと医療知識の進歩により、整形外科的損傷の治療を求める人が増え、軟部組織修復処置の需要を牽引しています。これらの要因が整形外科軟部組織市場の収益を押し上げています。

高齢者と肥満率の増加

高齢化人口の増加と慢性疾患の発生は、軟部組織修復市場を大きく牽引しています。例えば、世界保健機関（WHO）によると、2030年までに世界の6人に1人が60歳以上になるといいます。この時、60歳以上の人口比率は2020年の10億人から14億人に増加します。2050年には、世界の60歳以上の人口は倍増する（21億人）。80歳以上の人口は2020～2050年の間に3倍になり、4億2,600万人に達すると予想されています。肥満率の大幅な上昇は、糖尿病や心血管・腎臓関連疾患などの慢性疾患の増加につながっています。例えば、2023年に世界保健機関（WHO）が発表した報告書によると、2014年には18歳以上の成人の8.5％が糖尿病を患っていました。2019年には、糖尿病が150万人の死亡の直接の原因となり、48％が70歳以下で発生しています。糖尿病はさらに46万人の腎疾患死亡の原因となり、高血糖は心血管死亡の約20％の原因でした。2000～2019年にかけて、年齢標準化した糖尿病死亡率は3％増加しました。糖尿病関連死亡率は、低・中所得国で13％増加しています。さらに、米国整形外科学会が発表した紙製によると、肥満は通常、軟部組織の損傷や関節の退行性消耗状態である変形性関節症と関連しています。肥満は股関節や膝関節の変形性関節症に大きな影響を与えます。人間の体重1ポンドにつき4～6ポンドの圧力が膝関節にかかります。肥満の人が人工膝関節置換術を必要とする確率は、太っていない人に比べて20倍も高いです。このような要因が、整形外科軟部組織修復市場のシェアをさらに押し上げています。

技術の進歩

技術の進歩は、整形外科軟部組織修復市場の成長を促進する上で重要な役割を果たしています。これらの進歩は、より効果的で侵襲性の低い治療法の開発に貢献し、患者の予後を改善し、回復時間を短縮します。さらに、技術革新により、関節鏡や腹腔鏡などの低侵襲手術手技が開発され、従来型開腹手術に比べて、周辺組織への外傷を減らし、傷跡を最小限に抑え、回復時間を早めています。例えば、2023年7月、世界の医療技術事業を展開するSmith+Nephewは、インドでREGENETEN生体誘導インプラントを発売しました。REGENETENインプラントは、外科医の腱板手術へのアプローチ方法を変革し、その開始以来、世界中で10万件以上の手術が行われています。コラーゲンベースのリジェネテン生体誘導インプラントは、身体の自然治癒反応を刺激し、新しい腱様組織の開発を可能にして、現在の腱を自然に強化し、病気の進行を変えます。切手ほどの大きさのこのインプラントは、腱板腱の損傷部位を小さく切開し、関節鏡視下で投与されます。これとは別に、主要参入企業による様々な開発も、組織修復の需要を高めています。例えば、2021年8月、Orthopaedic Implant Companyは、FDA認可のDRPX手首骨折プレートを発表しました。このプレートは、タイプⅡの陽極酸化チタンと、軟部組織のインピンジメントを軽減する薄型のプレートとスクリューデザインを特徴としています。これらの要因は、整形外科軟部組織修復市場予測にプラスの影響を与えています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 世界の整形外科軟部組織修復市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：手技別

• 十字靭帯修復
• 回旋腱板修復
• 上腕骨外側上顆炎
• アキレス腱炎の修復
• 骨盤臓器脱
• 臀筋腱の修復
• 股関節鏡検査
• 上腕二頭筋腱固定術
• その他

第7章 市場内訳：負傷部位別

• 膝
• 肩
• 腰
• 小関節

第8章 市場内訳：エンドユーザー別

• 病院
• 外来センター
• 整形外科クリニック

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Arthrex Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Integra LifeSciences
  • Johnson & Johnson
  • LifeNet Health
  • MTF Biologics
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Group plc
  • Zimmer Biomet

List of Figures

• Figure 1: Global: Orthopedic Soft Tissue Repair Market: Major Drivers and Challenges
• Figure 2: Global: Orthopedic Soft Tissue Repair Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Orthopedic Soft Tissue Repair Market: Breakup by Procedure (in %), 2024
• Figure 5: Global: Orthopedic Soft Tissue Repair Market: Breakup by Injury Location (in %), 2024
• Figure 6: Global: Orthopedic Soft Tissue Repair Market: Breakup by End User (in %), 2024
• Figure 7: Global: Orthopedic Soft Tissue Repair Market: Breakup by Region (in %), 2024
• Figure 8: Global: Orthopedic Soft Tissue Repair (Cruciate Ligaments Repair) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Orthopedic Soft Tissue Repair (Cruciate Ligaments Repair) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Orthopedic Soft Tissue Repair (Rotator Cuff Repair) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Orthopedic Soft Tissue Repair (Rotator Cuff Repair) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Orthopedic Soft Tissue Repair (Lateral Epicondylitis) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Orthopedic Soft Tissue Repair (Lateral Epicondylitis) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Orthopedic Soft Tissue Repair (Achilles Tendinosis Repair) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Orthopedic Soft Tissue Repair (Achilles Tendinosis Repair) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Orthopedic Soft Tissue Repair (Pelvic Organ Prolapse) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Orthopedic Soft Tissue Repair (Pelvic Organ Prolapse) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Orthopedic Soft Tissue Repair (Gluteal Tendon Repair) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Orthopedic Soft Tissue Repair (Gluteal Tendon Repair) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Orthopedic Soft Tissue Repair (Hip Arthroscopy) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Orthopedic Soft Tissue Repair (Hip Arthroscopy) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Orthopedic Soft Tissue Repair (Biceps Tenodesis) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Orthopedic Soft Tissue Repair (Biceps Tenodesis) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Global: Orthopedic Soft Tissue Repair (Other Procedures) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Global: Orthopedic Soft Tissue Repair (Other Procedures) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Global: Orthopedic Soft Tissue Repair (Knee) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Global: Orthopedic Soft Tissue Repair (Knee) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Global: Orthopedic Soft Tissue Repair (Shoulder) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Global: Orthopedic Soft Tissue Repair (Shoulder) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: Global: Orthopedic Soft Tissue Repair (Hip) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: Global: Orthopedic Soft Tissue Repair (Hip) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: Global: Orthopedic Soft Tissue Repair (Small Joints) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: Global: Orthopedic Soft Tissue Repair (Small Joints) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Global: Orthopedic Soft Tissue Repair (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Global: Orthopedic Soft Tissue Repair (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Global: Orthopedic Soft Tissue Repair (Ambulatory Centers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Global: Orthopedic Soft Tissue Repair (Ambulatory Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: Global: Orthopedic Soft Tissue Repair (Orthopedic Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: Global: Orthopedic Soft Tissue Repair (Orthopedic Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: North America: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: North America: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: United States: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: United States: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: Canada: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Canada: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Asia-Pacific: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Asia-Pacific: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: China: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: China: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Japan: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Japan: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: India: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: India: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: South Korea: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: South Korea: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Australia: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Australia: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Indonesia: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: Indonesia: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Others: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Others: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Europe: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Europe: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Germany: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Germany: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: France: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: France: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: United Kingdom: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: United Kingdom: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Italy: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Italy: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Spain: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Spain: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Russia: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Russia: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Others: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Others: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 78: Latin America: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 79: Latin America: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 80: Brazil: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 81: Brazil: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 82: Mexico: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 83: Mexico: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 84: Others: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 85: Others: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 86: Middle East and Africa: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2019 & 2024
• Figure 87: Middle East and Africa: Orthopedic Soft Tissue Repair Market: Breakup by Country (in %), 2024
• Figure 88: Middle East and Africa: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 89: Global: Orthopedic Soft Tissue Repair Industry: SWOT Analysis
• Figure 90: Global: Orthopedic Soft Tissue Repair Industry: Value Chain Analysis
• Figure 91: Global: Orthopedic Soft Tissue Repair Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Orthopedic Soft Tissue Repair Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
• Table 3: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by Injury Location (in Million USD), 2025-2033
• Table 4: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 5: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Orthopedic Soft Tissue Repair Market: Competitive Structure
• Table 7: Global: Orthopedic Soft Tissue Repair Market: Key Players

The global orthopedic soft tissue repair market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 3.94% during 2025-2033. The rising geriatric population, continuous technological advancements in the medical sector, growing participation in sports activities, etc., are some of the major factors propelling the market growth.

Orthopedic Soft Tissue Repair Market Analysis:

• Major Market Drivers: The growing participation of individuals in professional sports has significantly increased the risks of sports-related injuries, which, in turn, is facilitating the orthopedic soft tissue repair market demand. Moreover, the introduction of new therapies, such as platelet-rich plasma, that are effective in managing complex neuromuscular pain caused due to orthopedic ligament tears is proliferating the industry's growth.
• Key Market Trends: The increasing penetration of advanced technologies, including bioprinting, biological meshes, and bio-fabrication is anticipated to proliferate the orthopedic soft tissue repair market demand. In addition, extensive research and development (R&D) activities, innovations in new devices and therapies, and increasing healthcare per capita expenditure, are also contributing to the market growth.
• Competitive Landscape: Some of the leading orthopedic soft tissue repair market companies are Arthrex Inc., Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Integra LifeSciences, Johnson & Johnson, LifeNet Health, MTF Biologics, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Group plc, and Zimmer Biomet, among others.
• Geographical Trends: The North America and Europe markets hold prominent shares of the orthopedic soft tissue repair market. Numerous factors, such as a large aging population, high prevalence of sports-related injuries, advanced healthcare infrastructure, and robust reimbursement systems, contribute to the market growth in these regions. Moreover, in the Asia Pacific region, improving healthcare infrastructures, rising disposable incomes, and growing awareness of advanced treatment options drive the market expansion.
• Challenges and Opportunities: Cost containment of soft tissue procedures, regulatory hurdles, technological complexity, and high competition among key players are some of the major challenges that the market is facing. However, ongoing research and development efforts lead to the development of innovative technologies and biomaterials for soft tissue repair, improving procedural outcomes and patient recovery times, thereby escalating the industry demand.

Orthopedic Soft Tissue Repair Market Trends:

Rising Incidences of Orthopedic Injuries

The increasing occurrence of orthopedic injuries is significantly propelling the orthopedic soft tissue repair market forward. Rising participation in physical activities and sports is leading to a rise in the incidence of orthopedic injuries. According to the National Athletic Trainers' Association, around 30 million children participated in organized sports in the United States in 2022. This figure has risen over time, as youth sports leagues have grown in popularity. This is further escalating the number of sports injuries. For instance, according to an article published by the Centers for Disease Control and Prevention (CDC), over 3.5 million sports-related injuries occur each year in the United States. In addition to this, a study conducted in Canada in 2022 revealed a significant percentage of injuries among contact sports participants in Canadian high schools. The survey also found that injury rates varied from 12.7 per 100 participants per year in rugby to 33.1 per 100 participants per year in ice hockey. The prevalence rate of head injuries was 33.3%; wrist or hand injuries were 16.0%; shoulder injuries were 12.8%; and knee injuries were 12.0%. This covers both minor and catastrophic injuries. As people engage in more physical activities and sports, the likelihood of sustaining soft tissue injuries rises. These injuries can range from ligament tears to tendon ruptures, requiring surgical intervention for repair. Apart from this, the aging population, coupled with a higher prevalence of chronic conditions such as osteoarthritis, also drives the demand for orthopedic interventions, including soft tissue repair. For instance, according to an article published by the Cleveland Clinic, more than 80% of adults older than 55 had osteoarthritis. Furthermore, with growing awareness about the importance of orthopedic health and advancements in medical knowledge, more people are seeking treatment for orthopedic injuries, driving the demand for soft tissue repair procedures. These factors are bolstering the orthopedic soft tissue market revenue.

Escalating Geriatric Population and Obesity Rates

The rise in the aging population and chronic disease occurrences is significantly driving the soft tissue repair market. For instance, according to the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up would rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of people aged 60 and up would double (2.1 billion). The number of people aged 80 and older was anticipated to treble between 2020 and 2050, reaching 426 million. The significant rise in obesity rates is leading to the increasing incidence of chronic diseases such as diabetes, and cardiovascular and kidney-related illnesses. For instance, according to a report published by the World Health Organization in 2023, in 2014, 8.5% of adults aged 18 and up had diabetes. In 2019, diabetes was the direct cause of 1.5 million fatalities, with 48% occurring before the age of 70. Diabetes caused an additional 460,000 renal disease deaths, and high blood glucose was responsible for approximately 20% of cardiovascular fatalities. Between 2000 and 2019, age-standardized diabetes mortality rates increased by 3%. Diabetes-related mortality has increased by 13% in low- and middle-income nations. Moreover, according to an article published by the American Academy of Orthopedic Surgeons, obesity is usually associated with soft tissue injury and osteoarthritis, a degenerative wear and tear condition of the joints. Obesity has a significant impact on osteoarthritis of the hip and knee joints. Every pound of human weight applies four to six pounds of pressure on each knee joint. Obese people are 20 times more likely to require a knee replacement than those who are not overweight. These factors are further contributing to the orthopedic soft tissue repair market share.

Technological Advancements

Technological advancements play a crucial role in driving the growth of the orthopedic soft tissue repair market. These advancements contribute to the development of more effective and less invasive treatment options, enhancing patient outcomes and reducing recovery times. Moreover, technological innovations have led to the development of minimally invasive surgical techniques, such as arthroscopy and laparoscopy, which reduce trauma to surrounding tissues, minimize scarring, and accelerate recovery times compared to traditional open surgeries. For instance, in July 2023, Smith+Nephew, the worldwide medical technology business, launched REGENETEN bioinductive implant in India. The REGENETEN implant has transformed the way surgeons approach rotator cuff surgeries, with over 100,000 procedures conducted globally since its inception. The collagen-based REGENETEN bioinductive implant stimulated the body's natural healing response, allowing the development of new tendon-like tissue to naturally enhance the current tendon and alter disease progression. The implant, roughly the size of a postage stamp is delivered arthroscopically through a small incision over the region of the rotator cuff tendon injury. Apart from this, various developments by the key players are also enhancing the demand for tissue repair. For example, in August 2021, Orthopaedic Implant Company introduced its FDA-cleared DRPX wrist fracture plate, which features type II anodized titanium and a low-profile plate and screw design to reduce soft tissue impingement. These factors are positively influencing the orthopedic soft tissue repair market forecast.

Orthopedic Soft Tissue Repair Industry Segmentation:

Breakup by Procedure:

• Cruciate Ligaments Repair
• Rotator Cuff Repair
• Lateral Epicondylitis
• Achilles Tendinosis Repair
• Pelvic Organ Prolapse
• Gluteal Tendon Repair
• Hip Arthroscopy
• Biceps Tenodesis
• Others

According to the orthopedic soft tissue repair market outlook, cruciate ligaments repair is commonly performed to reconstruct a torn anterior cruciate ligament (ACL) in the knee, which often occurs during sports injuries. Demand for this procedure tends to be consistent due to the prevalence of sports-related injuries. While rotator cuff repair is a group of muscles and tendons that stabilize the shoulder joint. Tears in the rotator cuff are common, especially among older adults and athletes engaged in overhead activities. The demand for rotator cuff repair remains steady due to the aging population and continued participation in sports. Moreover, lateral epicondylitis, commonly known as tennis elbow, is inflammation of the tendons that join the forearm muscles on the outside of the elbow. Treatment options include conservative measures like rest, physical therapy, and corticosteroid injections, but in some cases, surgical intervention may be necessary.

Breakup by Injury Location:

• Knee
• Shoulder
• Hip
• Small Joints

According to the orthopedic soft tissue repair market outlook, the demand for soft tissue repair procedures in the knee, shoulder, hip, and small joints can vary based on several factors, including the prevalence of injuries, demographic trends, advancements in surgical techniques, and changes in patient preferences. There has been a noted increase in the incidence of ACL knee tears, especially among young athletes participating in high-impact sports like soccer, basketball, and football. Factors contributing to this rise may include increased sports participation, year-round training, and higher intensity levels. Moreover, there has been a rise in rotator cuff injuries in the shoulder, particularly among individuals over 40, possibly due to aging demographics, increased sports participation among older adults, and occupational demands.

Breakup by End User:

• Hospitals
• Ambulatory Centers
• Orthopedic Clinics

Hospitals often handle acute soft tissue injuries requiring immediate attention, such as traumatic ligament tears, tendon ruptures, or severe joint dislocations. Soft tissue repair procedures performed in hospitals may include complex surgeries or revisions. Hospitals can accommodate patients requiring overnight stays or post-operative monitoring, which may be necessary for certain soft tissue repair procedures with extended recovery periods or higher risk profiles. Moreover, ASCs are increasingly popular for performing elective soft tissue repair procedures that do not require overnight hospitalization, such as arthroscopic surgeries for meniscal tears or rotator cuff repairs. Apart from this, orthopedic clinics focus exclusively on musculoskeletal conditions and surgeries, including soft tissue repair procedures. Patients seeking specialized orthopedic care may prefer these clinics for comprehensive evaluations, treatment planning, and post-operative rehabilitation.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

According to the orthopedic soft tissue market statistics, the North America region, including the United States and Canada, has well-established medical systems with high levels of healthcare expenditure. Factors such as a large aging population, increasing sports participation, and advancements in medical technology drive the demand for orthopedic soft tissue repair procedures. Moreover, in Europe, countries like Germany, France, and the United Kingdom, have sophisticated healthcare infrastructure and high demand for orthopedic procedures. Additionally, the orthopedic soft tissue repair market in the Asia Pacific region is rapidly expanding due to urbanization, the aging population, and increasing healthcare expenditures. The government's healthcare reforms and investments in medical infrastructure further boost the market growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players that are:

• Arthrex Inc.
• Becton Dickinson and Company
• Boston Scientific Corporation
• CONMED Corporation
• Integra LifeSciences
• Johnson & Johnson
• LifeNet Health
• MTF Biologics
• Smith & Nephew plc
• Stryker Corporation
• Tissue Regenix Group plc
• Zimmer Biomet

Key Questions Answered in This Report

• 1.How big is the orthopedic soft tissue repair market?
• 2.What is the future outlook of orthopedic soft tissue repair market?
• 3.What are the key factors driving the orthopedic soft tissue repair market?
• 4.Which region accounts for the largest orthopedic soft tissue repair market share?
• 5.Which are the leading companies in the global orthopedic soft tissue repair market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Orthopedic Soft Tissue Repair Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Procedure

• 6.1 Cruciate Ligaments Repair
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Rotator Cuff Repair
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Lateral Epicondylitis
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Achilles Tendinosis Repair
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Pelvic Organ Prolapse
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Gluteal Tendon Repair
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Hip Arthroscopy
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast
• 6.8 Biceps Tenodesis
  • 6.8.1 Market Trends
  • 6.8.2 Market Forecast
• 6.9 Others
  • 6.9.1 Market Trends
  • 6.9.2 Market Forecast

7 Market Breakup by Injury Location

• 7.1 Knee
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Shoulder
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Hip
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Small Joints
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Orthopedic Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Arthrex Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Boston Scientific Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
  • 14.3.4 CONMED Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Integra LifeSciences
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Johnson & Johnson
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 LifeNet Health
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 MTF Biologics
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Smith & Nephew plc
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Stryker Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Tissue Regenix Group plc
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
  • 14.3.12 Zimmer Biomet
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis